当前位置:首页 - 行情中心 - 康美药业(600518) - 财务分析 - 资产负债表

康美药业

(600518)

  

流通市值:183.84亿  总市值:183.92亿
流通股本:138.22亿   总股本:138.29亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金1,345,267,876.011,228,787,192.411,240,084,497.951,180,626,875.64
  交易性金融资产112,437.0283,435.6887,646.5191,402.64
  应收票据及应收账款2,244,467,291.392,430,082,161.632,361,199,506.752,519,001,801.67
  其中:应收票据55,069,994.7162,399,561.6361,969,126.1345,396,096.1
        应收账款2,189,397,296.682,367,682,6002,299,230,380.622,473,605,705.57
  应收款项融资33,361,127.3235,144,488.163,223,246.4555,238,978.27
  预付款项137,286,990.28128,077,382.86142,596,682.0987,677,133.58
  其他应收款合计458,151,355.06455,268,356.1451,265,880.87574,344,551.93
  存货2,303,563,002.222,378,798,285.972,236,515,651.52,452,703,655.87
  其他流动资产137,823,359.19147,226,434.87156,455,168.86159,616,923.15
  流动资产合计6,660,033,438.496,803,467,737.626,651,428,280.987,029,301,322.75
非流动资产:
  其他权益工具投资1,051,059.421,045,458.571,044,664.831,045,560.24
  投资性房地产2,501,112,350.722,510,830,621.932,534,223,667.592,682,870,160.98
  固定资产3,093,669,967.33,164,510,086.63,204,070,255.173,068,634,809.9
  在建工程176,321,714.87175,686,182.84164,800,076.86170,681,750.53
  生产性生物资产350,343.85354,523.12358,702.39366,842.66
  使用权资产84,050,371.7286,534,234.7482,051,926.793,032,657.78
  无形资产407,126,124.27409,019,671.4413,934,506.89391,476,344.91
  商誉36,909,405.6136,909,405.6136,909,405.61106,350,551.22
  长期待摊费用44,572,103.4747,409,470.9949,987,043.3649,436,826.61
  递延所得税资产56,494,082.2864,065,485.5364,172,303.2467,526,844.48
  其他非流动资产6,285,897.467,453,338.1516,765,153.8822,210,835.91
  非流动资产合计6,407,943,420.976,503,818,479.486,568,317,706.526,653,633,185.22
  资产总计13,067,976,859.4613,307,286,217.113,219,745,987.513,682,934,507.97
流动负债:
  短期借款78,791,135.3281,592,942.4690,931,770.5214,839,858.44
  应付票据及应付账款2,269,712,329.042,455,043,400.622,354,806,456.32,608,535,602.99
  其中:应付票据152,845,224.51167,518,054.17124,333,748.2674,694,835.99
        应付账款2,116,867,104.532,287,525,346.452,230,472,708.042,533,840,767
  预收款项37,051,884.1549,226,337.4848,908,196.960,217,549.57
  合同负债155,641,103.07112,071,696.0691,696,441.12146,866,646.77
  应付职工薪酬59,595,876.9666,492,613.9570,848,303.6258,809,559.17
  应交税费428,136,605.99424,921,788.2425,574,193.96418,707,947.52
  其他应付款合计1,085,255,965.41,190,382,733.941,184,641,797.751,252,239,614.92
        应付股利4,500,0004,750,0005,000,0002,250,000
  一年内到期的非流动负债22,717,330.3423,547,256.4323,544,474.3325,302,411.46
  其他流动负债960,238,584.28974,339,884974,939,354.281,225,891,717.94
  流动负债合计5,097,140,814.555,377,618,653.145,265,890,988.785,811,410,908.78
非流动负债:
  租赁负债67,346,961.7568,571,833.7569,888,199.6778,445,921.89
  预计负债13,542,588.4216,205,452.0616,248,337.0617,092,873.6
  递延收益508,779,451.85516,200,756.88523,013,728.48530,151,217.7
  递延所得税负债18,746,414.8419,185,619.2619,297,198.5321,150,419.62
  非流动负债合计608,415,416.86620,163,661.95628,447,463.74646,840,432.81
  负债合计5,705,556,231.415,997,782,315.095,894,338,452.526,458,251,341.59
所有者权益(或股东权益):
  实收资本(或股本)13,828,896,69013,828,896,69013,828,896,69013,828,896,690
  资本公积18,474,263,009.5718,474,263,009.5718,474,263,009.5718,474,263,009.57
  减:库存股659,922,053.5659,922,053.5659,922,053.5763,916,500
  其他综合收益-370,266.33-361,053.62-345,247.63-333,915.4
  专项储备3,241,853.923,663,932.713,571,061.851,567,853.73
  盈余公积1,525,575,798.271,525,575,798.271,525,575,798.271,525,575,798.27
  未分配利润-25,845,998,195.11-25,898,596,860.1-25,882,032,977.71-25,879,278,666.17
  归属于母公司股东权益合计7,325,686,836.827,273,519,463.337,290,006,280.857,186,774,270
  少数股东权益36,733,791.2335,984,438.6835,401,254.1337,908,896.38
  股东权益合计7,362,420,628.057,309,503,902.017,325,407,534.987,224,683,166.38
  负债和股东权益合计13,067,976,859.4613,307,286,217.113,219,745,987.513,682,934,507.97
公告日期2026-08-262026-04-302026-04-182025-10-31
审计意见(境内)标准无保留意见
TOP↑